Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 19/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.52 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.52 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.50 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28162273 | 0.82 | CYP1A2 (0.45) | SLC22A12NCOA3 | |
| SCHEMBL17540554 | 0.81 | SLC22A12 (0.56) | SLC22A12SLC22A6SLC22A11ABCG2NCOA3 | |
| SCHEMBL19072727 | 0.78 | AR (0.47) | SLC22A12 | |
| SCHEMBL28964831 | 0.78 | ALDH1A1 (0.41) | SLC22A12NCOA3 | |
| SCHEMBL16917824 | 0.77 | IMPDH2 (0.57) | SLC22A12SLC22A6SLC22A11 | |
| SCHEMBL21350516 | 0.77 | SLC22A12 (0.56) | SLC22A12SLC22A6SLC22A11ABCG2NCOA3 | |
| SCHEMBL19240219 | 0.76 | SLC22A12 (0.58) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL19240216 | 0.75 | SLC22A12 (0.66) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL19556669 | 0.75 | SLC22A12 (0.74) | SLC22A12SLC22A6SLC22A11ABCG2 | |
| SCHEMBL19240232 | 0.75 | SLC22A12 (0.70) | SLC22A12SLC22A6SLC22A11ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108863919-B | Sulfonamide compound for treating gout or hyperuricemia and preparation method thereof | 海创药业股份有限公司 | 2021-04-02 | — | — | CN | disclosed |